Active Ingredient History

  • Now
Ibutilide is a 'pure' class III antiarrhythmic drug, used intravenously against atrial flutter and fibrillation. At a cellular level it exerts two main actions: induction of a persistent Na+ current sensitive to dihydropyridine Ca2+ channel blockers and potent inhibition of the cardiac rapid delayed rectifier K+ current, by binding within potassium channel pores. In other words, Ibutilide binds to and alters the activity of hERG potassium channels, delayed inward rectifier potassium (IKr) channels and L-type (dihydropyridine sensitive) calcium channels. Ibutilide is indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm. Ibutilide is marketed as Corvert by Pfizer.   NCATS

  • SMILES: CCCCCCCN(CC)CCCC(O)c1ccc(NS(=O)(=O)C)cc1.CCCCCCCN(CC)CCCC(O)c2ccc(NS(=O)(=O)C)cc2.OC(=O)\C=C\C(=O)O
  • Mol. Mass: 885.24
  • ALogP: 4.16
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

corvert | ibutilid | ibutilida | ibutilide | ibutilide fumarate | ibutilide, fumarate salt (2:1), (+-)-isomer | ibutilide, fumarate salt (2:1), (+)-isomer | ibutilide, (-)-isomer | ibutilide, (+-)-isomer | ibutilide, (+)-isomer | ibutilidum | n-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide | n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide | u-70226e | u82208e | u-82208e | u82209e | u 82209e | u-82209e


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue